264. Neuro: Using Brain-Computer Interface to solve motor impairment with Kurt Haggstrom, Chief Commercial Officer at Synchron

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions00:00 Introduction to Neurotech and Synchron01:48 Kurt Hagstrom's Journey in MedTech05:11 Transitioning to Synchron and BCI Innovation10:01 Understanding the Need for BCI Technology13:16 Challenges in the BCI Field18:14 Synchron's Unique Approach to BCI22:15 Adoption and Implementation of BCI Technology24:12 Maximizing Visibility in MedTech26:59 Innovations in Brain-Computer Interfaces30:31 Understanding the Interventional Neurology Landscape32:29 Restoring Mobility Through Technology36:48 The Future of Neurotechnology41:10 Clinical Trials and Patient EngagementAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our newsletter: https://www.stateofmedtechpodcast.com/Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfgFollow The State of MedTech on:⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠TikTok⁠⁠⁠⁠X⁠⁠⁠⁠Facebook⁠⁠⁠⁠Follow Omar M. Khateeb on⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠TikTok⁠⁠⁠⁠X⁠⁠⁠⁠Facebook⁠⁠This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.